Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Aberrant Channel Subunit Trafficking in the Neurodegenerative KCNC3/R420H SCA13 Phenotype
Neurogenetics and Gene Therapy
(-)
005
Authors/Disclosures
Michael F. Waters, MD, PhD, FÂé¶¹´«Ã½Ó³»­ (Mount Sinai Scholl of Medicine) Dr. Waters has nothing to disclose.
Duong Huynh, PhD (Cedars-Sinai Medical Center/UCLA) No disclosure on file
Arshi Naz, MD No disclosure on file
Karla P. Figueroa (University of Utah) Ms. Figueroa has nothing to disclose.
Stefan M. Pulst, MD, FÂé¶¹´«Ã½Ó³»­ (University of Utah) Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for venrock. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leverna. Dr. Pulst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Âé¶¹´«Ã½Ó³»­. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Leninthal LLC. The institution of Dr. Pulst has received research support from NINDS. Dr. Pulst has received intellectual property interests from a discovery or technology relating to health care.
Saeed A. Bohlega, MD (King Faisal Specialist Hospital & Research Centre) No disclosure on file